PROM1 and melanoma: These data add to the growing body of evidence that the surface marker CD133 does not label a cancer stem cell/tumour initiating cell in melanoma, and clearly demonstrates that both CD133+ and CD133- populations contain cells capable of initiating and maintaining tumours.